Form4insider filings, from the source

SEC Form 4 · accession 0001567619-18-007116

Emergent BioSolutions Inc. · EBS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Sue Bailey
Director
Period of report
Nov 27, 2018
Accepted (ET)
Nov 29, 2018 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockNov 27, 2018M8,244$18.64A57,216D
Common StockF1Nov 27, 2018S8,244$69.6197D48,972D
Common StockNov 27, 2018M1,579$20.08A50,551D
Common StockF1Nov 27, 2018S1,579$69.6197D48,972D
Common StockNov 27, 2018M4,736$13.00A53,708D
Common StockF1Nov 27, 2018S4,736$69.6197D48,972D
Common StockNov 27, 2018M3,158$13.37A52,130D
Common StockF1Nov 27, 2018S3,158$69.6197D48,972D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to buy)F2,F3$18.64Nov 27, 2018M8,244D—May 21, 2021Common Stock8,2440D
Stock Option (Right to buy)F2,F3$20.08Nov 27, 2018M1,579D—May 18, 2021Common Stock1,5790D
Stock Option (Right to buy)F2,F3$13.00Nov 27, 2018M4,736D—May 22, 2020Common Stock4,7360D
Stock Option (Right to buy)F2,F3$13.37Nov 27, 2018M3,158D—May 16, 2019Common Stock3,1580D

Explanation of responses